<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 21 Jul 2026 16:40:54 -0400--><rss version="2.0">
    <channel>
        <title>FibroBiologics, Inc. (FBLG) SEC Filings</title>
        <link>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/rss</link>
        <description>FibroBiologics, Inc. (FBLG) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_14a954ff2903678ce9699bf59a0e1fd9/fibrobiologics/files/theme/images/logo-sm.png</url>
                <title>FibroBiologics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[EFFECT - Notice of Effectiveness]]></title>
                <description><![CDATA[EFFECT]]></description>
                <link>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/9999999995-26-002341/9999999995-26-002341.pdf</link>
                <pubDate>Fri, 17 Jul 26 06:04:02 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/9999999995-26-002341/9999999995-26-002341.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition]]></title>
                <description><![CDATA[PRE 14A]]></description>
                <link>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-307822/0001193125-26-307822.pdf</link>
                <pubDate>Fri, 17 Jul 26 16:32:24 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-307822/0001193125-26-307822.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]></title>
                <description><![CDATA[424B3]]></description>
                <link>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-306114/0001193125-26-306114.pdf</link>
                <pubDate>Thu, 16 Jul 26 16:12:26 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-306114/0001193125-26-306114.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[3 - Initial statement of beneficial ownership of securities]]></title>
                <description><![CDATA[2 Related Documents: 3, EX-24]]></description>
                <link>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-033509/0001493152-26-033509.pdf</link>
                <pubDate>Thu, 16 Jul 26 16:01:06 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-033509/0001493152-26-033509.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[S-3 - Registration statement under Securities Act of 1933]]></title>
                <description><![CDATA[4 Related Documents: S-3, EX-5.1, EX-23.2, EX-FILING FEES]]></description>
                <link>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-299884/0001193125-26-299884.pdf</link>
                <pubDate>Fri, 10 Jul 26 06:02:06 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-299884/0001193125-26-299884.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-299290/0001193125-26-299290.pdf</link>
                <pubDate>Thu, 09 Jul 26 09:31:58 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-299290/0001193125-26-299290.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[D - Notice of Exempt Offering of Securities]]></title>
                <description><![CDATA[D]]></description>
                <link>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-031095/0001493152-26-031095.pdf</link>
                <pubDate>Mon, 29 Jun 26 16:32:49 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-031095/0001493152-26-031095.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[8 Related Documents: 8-K, EX-4.1, EX-4.2, EX-4.3, EX-10.1, EX-10.2, EX-99.1, EX-99.2]]></description>
                <link>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-288468/0001193125-26-288468.pdf</link>
                <pubDate>Mon, 29 Jun 26 16:16:08 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-288468/0001193125-26-288468.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-029851/0001493152-26-029851.pdf</link>
                <pubDate>Tue, 23 Jun 26 20:02:41 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-029851/0001493152-26-029851.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-029850/0001493152-26-029850.pdf</link>
                <pubDate>Tue, 23 Jun 26 20:01:55 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-029850/0001493152-26-029850.pdf</guid>
                                                                            </item>
            </channel>
</rss>